LPL Financial LLC

Position in PCVX — Vaxcyte, Inc.

CIK 1403438 FORT MILL, SC

Position in PCVX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,166,959

-$420,838 QoQ

Shares Held

20,075

-26.5% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#154

of 329 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 32% Shared 0% None 68%

Healthcare · as of Jun 30, 2026

LPL Financial LLC holds $551,304,275 across 203 Biotechnology names. PCVX ranks #57 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	289,111	$143,610,107
2	REGN	Regeneron Pharmaceuticals, Inc.	65,755	$41,000,872
3	ARWR	Arrowhead Pharmaceuticals, Inc.	310,761	$25,330,129
4	ARGX	Argenx SE	19,499	$18,090,587
5	ALNY	Alnylam Pharmaceuticals, Inc.	57,890	$17,426,626
6	HALO	Halozyme Therapeutics, Inc.	203,557	$15,932,406
7	RPRX	Royalty Pharma plc	249,117	$13,967,990
8	INSM	INSMED Inc	128,553	$13,706,320

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,166,959	20,075	-26.5%	Shares	Sole	2026-08-07
2026-03-31	$1,587,797	27,324	+33.4%	Shares	Sole	2026-05-06
2025-12-31	$945,362	20,489	+6.1%	Shares	Sole	2026-02-11
2025-09-30	$695,798	19,317	+51.7%	Shares	Sole	2025-11-12
2025-06-30	$414,014	12,735	+43.4%	Shares	Sole	2025-08-12
2025-03-31	$335,346	8,881	+35.3%	Shares	Sole	2025-05-07
2024-12-31	$537,247	6,563	-51.3%	Shares	Sole	2025-02-11
2024-09-30	$1,538,645	13,465	+41.5%	Shares	Sole	2024-11-08
2024-06-30	$718,704	9,518	+11.2%	Shares	Sole	2024-08-07
2024-03-31	$584,870	8,562	-20.5%	Shares	Sole	2024-05-10
2023-12-31	$675,979	10,764	+11.8%	Shares	Sole	2024-02-14
2023-09-30	$490,682	9,625	+11.9%	Shares	Sole	2023-11-13
2023-06-30	$429,384	8,598	—	Shares	Sole	2023-07-31
No filing history on record for this holder in this stock.